Table 3.
No-TXA (n=62) |
TXA (n=31) |
P | |
---|---|---|---|
Mortality, % | |||
6-hours | 34% | 13% | 0.04 |
12-hour | 36% | 23% | 0.24 |
18-hour | 39% | 23% | 0.16 |
24-hour | 39% | 26% | 0.25 |
30-day | 50% | 45% | 0.82 |
Transfusions in 24 hours, Units, median [IQR] | |||
RBC | 12 [7–22] | 15 [10–33] | 0.11 |
Plasma | 10 [3–16] | 15 [7–22] | 0.03 |
Platelets | 10 [6–18] | 13 [7–19] | 0.13 |
Time to achieve hemostasis, min [IQR] | 158 [87─243] | 139 [86─255] | 0.65 |
Re-bleeding requiring intervention, % | 3.2% | 9.7% | 0.13 |
Cause of death, % | |||
Exsanguination/Hemorrhagic shock | 32% | 26% | 0.39 |
TBI | 13% | 10% | 0.62 |
Respiratory | 1.6% | 6.4% | 0.26 |
Other | 3.2% | 3.2% | 1.00 |
Min=Minutes, IQR=Interquartile Range